BetterLife Pharma Inc. (NPAU.F)

0,0615 +0,0005 (+0,82%) Ab 08:10AM CEST. Markt geöffnet.

BetterLife Pharma Inc.

1275 West 6th Avenue
Suit 300
Vancouver, BC V6H 1A6
Canada
604 221 0595
https://www.abetterlifepharma.com

Sektor(en): Healthcare
Branche: Biotechnology
Vollzeitmitarbeiter: 

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Dr. Ahmad Doroudian Ph.D.	Founder, CEO & Chairman	204,16k	N/A	1960
Ms. Moira Ong C.A., CPA, CA, CFA	Chief Financial Officer	179,66k	N/A	1975
Dr. Hooshmand Sheshbaradaran Ph.D.	Chief Operating Officer	227,24k	N/A	1968
Dr. Stephen Sangha	Corporate Development Advisor	N/A	N/A	N/A
Mr. Scott Rudge Ph.D.	Head of CMC	N/A	N/A	N/A
Anthony Calandra Ph.D.	Head of Regulatory	N/A	N/A	N/A
Dr. Abdi Ghaffari Ph.D.	Head of Preclinical & Toxicology	N/A	N/A	N/A

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in EUR.

Beschreibung

BetterLife Pharma Inc., a biotechnology company, engages in the development and commercialization of compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections. The company's products pipeline includes BETR-001 for the treatment of major depressive disorder, anxiety, and neuropathic pain and other neuro-psychiatric and neurological disorders; and BETR-002 to treat benzodiazepine dependency, anxiety, and neurodegenerative disorders. It is also developing MM-003, which has completed Phase II clinical trials for treatment of COVID-19 and other respiratory viral infections; and MM-001, a topical cream for local intravaginal use to treat HPV-induced cervical intraepithelial neoplasia that has completed Phase II clinical trials. The company was formerly known as Pivot Pharmaceuticals Inc. and changed its name to BetterLife Pharma Inc. in December 2019. BetterLife Pharma Inc. was incorporated in 2002 and is headquartered in Vancouver, Canada.

Corporate Governance

BetterLife Pharma Inc.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.